Leading ride-share company Uber Technologies (NYSE: UBER) recently filed several trademarks that could suggest an expansion of the company’s business to a new sector.
The filings come years after the company exited the same business line.
Let’s dive in.
Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.